Skip to main content

Table 1 Colistin MICs and antimicrobial activity of biosurfactant extract ST34 (10.00 mg/mL) against a panel (n = 16) of MDR and XDR bacterial isolates

From: Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains

Organism

Strain Code

Source

Colistin MIC (mg/L)

Antimicrobial inhibition zone diameter (mm) ± SD

Surfactin Extract

A. baumannii

AB 1

ATCC

2 (S)

13.3 ± 1.2

AB 2

Clinical

2 (S)

14.7 ± 0.6

AB 4

Clinical

>  4a (R)

17.3 ± 0.6

AB 6

Environmental

2 (S)

11.7 ± 1.2

E. coli

EC 1

ATCC

4 (R)

12.7 ± 0.6

EC 2

Clinical

2 (S)

15.7 ± 0.6

EC 3

Clinical

>  4a (R)

15.7 ± 1.6

EC 4

Environmental

4 (R)

14 ± 0

EC 5

Environmental

4 (R)

17.7 ± 0.6

K. pneumoniae

KP 1

ATCC

4 (R)

14.3 ± 0.6

KP 4

Clinical

4 (R)

13.3 ± 0.6

KP 5

Environmental

>  4a (R)

13 ± 1

P. aeruginosa

PA 1

ATCC

4 (R)

13 ± 0

PA 2

Clinical

8 (R)

13 ± 0

PA 3

Clinical

4 (R)

13.3 ± 0.6

PA 4

Environmental

4 (R)

12.7 ± 0.6

  1. aCorresponds to a colistin concentration exceeding 4 mg/L; S susceptible; R resistant